drug discovery

"Named after the crystallographer who helped reveal the structure of DNA, GPT-Rosalind is OpenAI’s first domain-specific model series, fine-tuned for biochemistry, genomics, and protein engineering."

"OpenAI recently released a brand new AI model designed specifically for drug discovery and biomedical research, marking the company's official entry into the life sciences sector and initiating direct competition with Google."

"The fund, Sovereign AI, will invest roughly $675 million in homegrown startups in fields ranging from model development to agentic AI to drug discovery."

"OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows."

"According to the announcement, quantum error correction decoding using Ising achieves up to 2.5x higher speed and approximately 3x higher accuracy compared to conventional methods, while calibration work can be shortened from a matter of days to a matter of hours."

"They have developed environments in which people and AI collaborate on decisions. AI generates options, surfaces patterns, and flags what needs attention. It shows its work so you can verify. Humans review, add context, and make the final call."

"The sweeping collaboration will see OpenAI’s intelligent agents embedded across the drug maker’s workflows in order to enhance everything from lab-based drug discovery to the complexities [of drug delivery]"

"From those 15 million candidates, the team synthesised roughly 60 in the laboratory. They arrived at a promising scaffold now moving forward for further optimisation."

"If it were up to me, I would have kept AI in the lab longer, doing more things like AlphaFold—maybe curing cancer or something like that."

"OpenAI claims to be finalizing, “more than $100 million in grants this month, across six research institutions, to support and accelerate Alzheimer’s research.”"

"Generare Bioscience SAS, a Paris-based biotechnology company generating never-before-seen molecular data for drug development using 人工智能, announced today it has raised €20 million, about $23.3 million, in an early-stage funding round..."

"The transaction's core is a preclinical oral GLP-1 drug; in addition, based on Insilico Medicine's Pharma AI technology platform, the two parties will also conduct a number of research and development collaborations 'around targets selected by Lilly'."

"Quantum kernel methods are an approach that efficiently calculates inner products in high-dimensional feature spaces using quantum computers. It is particularly effective for the classification of ADMET (absorption, distribution, metabolism, excretion, and toxicity) characteristics."

"QAOA is an algorithm that solves combinatorial optimization problems using quantum computers. It transforms the problem of maximizing protein-ligand binding into QUBO (Quadratic Unconstrained Binary Optimization)."

"=== QAOA drug optimization results ==="

"The top AI docking methods (such as SurfDock) and co-folding methods (such as AlphaFold3), in dealing with the most challenging cross-conformation docking tasks, have comprehensively surpassed the physical models that have dominated the industry for decades."

"Eli Lilly will pay Insilico Medicine $115 million upfront, with the remaining payments tied to subsequent regulatory approvals and commercialization progress."

"Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments"

"Boltz-2 is a tool that uses AI to predict how biological molecules (proteins and drug molecules) bind."

""Agent能够高度整合各种AI模块，并与人类进行深度协同。 更关键的是，它在进行决策时，能够将前端证据收集、中端假设生成、及后端未来结果模拟，全部纳入当前的决策闭环。""

"Baker研究室はここで逆のことを考えた。予測ネットワークを逆向きに使えば、自然界に存在しないまったく新しいタンパク質を「生み出す」ことができるのではないか。"

"This shift enables data scientists to transition from "writing code" to "defining objectives and monitoring/controlling the agent's thought process.""

"Earendil Labs, a cutting-edge AI-driven pharmaceutical company spun out from Tsinghua University, is preparing for an IPO on the Hong Kong Stock Exchange."

"Roche's new deployment spans more than 3,500 NVIDIA Blackwell GPUs across its worldwide operations and embedded across the entire value chain, massively scaling R&D productivity, next-generation diagnostics and manufacturing efficiencies."

"AI is changing the pharmaceutical industry, and the question is no longer whether it can, but how strong its disruptive power will be."

"In the context of this, domestic AI pharmaceutical platform company Crystalgen Holdings announced a profit forecast for 2025: revenue increased to no less than 780 million yuan, an increase of at least 193% year-on-year; after-tax profit and profit attributable to the company's equity holders were no less than 100 million yuan, turning a loss into a profit year-on-year, and achieving annual profit for the first time, also becoming the first AI application stock in Hong Kong to achieve profit."

"Operating on the design principle of ``free-form reasoning for safe tasks, structured execution for long-horizon pipelines,'' Mozi provides built-in robustness mechanisms and trace-level audibility to completely mitigate error accumulation."

"“We are going to prove to the world that AI can truly deliver on its promise in drug development.”"

"AI is attempting to shed light on the darkness."